Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
SEC Filing
SEC Filing Details
Document Details
Form
Filing Date
Nov 18, 2019
Document Date
Nov 18, 2019
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Constellation Pharmaceuticals
Issuer
CONSTELLATION PHARMACEUTICALS INC
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com